Clinical Trial Update: A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of RS-C1001 tablets in Chinese healthy volunteers, with dyslipi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• RS-C1001 tablets

Snippet

Sponsor: Peking University First Hospital | Conditions: Dyslipidemia | Phase 1 | Status: RECRUITING